Publications by authors named "Adlette Inati"

Claim this Profile
I
Impact of COVID-19 on clinical outcomes and care delivery in pediatric oncology patients in Lebanon in 2020-2023: a retrospective study.
Peter Noun, May Farhat, Hassan Khalife, Jennifer Bou Younis, Mohamad Farhat, Adlette Inati

Front Pediatr· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of plasma-derived von Willebrand factor/factor VIII concentrate (wilate) prophylaxis in children and adolescents with von Willebrand disease - WIL-31 study post hoc analysis.
Robert F Sidonio, Leonid Dubey, Kateryna V Vilchevska, Adlette Inati, Claudia Djambas Khayat

Res Pract Thromb Haemost· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of mitapivat in sickle cell disease (RISE UP): results from the phase 2 portion of a global, double-blind, randomised, placebo-controlled trial.
Modupe Idowu, Lucas Otieno, Bogdan Dumitriu, Clarisse L C Lobo, Swee Lay Thein, Adlette Inati

Lancet Haematol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Wilate Prophylaxis in Reducing Nosebleeds in Patients with Severe VWD - A Post-hoc Analysis of the WIL-31 Study.
Ana Boban, Leonid Dubey, Kateryna V Vilchevska, Adlette Inati, Claudia Djambas Khayat

Clin Appl Thromb Hemost· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
von Willebrand factor/factor VIII concentrate (Wilate) prophylaxis in children and adults with von Willebrand disease.
Robert F Sidonio, Ana Boban, Leonid Dubey, Adlette Inati, Csongor Kiss

Blood Adv· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A homozygous frameshift variant expands the clinical spectrum of SAMD9 gene defects.
Cybel Mehawej, Maroun Ibrahim, Lynn Khalife, Eliane Chouery, Setrida El Hachem, Adlette Inati

Clin Genet· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum: Rotavirus Genotypes and Vaccine Effectiveness from a Sentinel, Hospital-Based, Surveillance Study for Three Consecutive Rotavirus Seasons in Lebanon.
Zainab Ali, Houda Harastani, Moza Hammadi, Lina Reslan, Soha Ghanem, Adlette Inati

PLoS One· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Ticagrelor vs placebo for the reduction of vaso-occlusive crises in pediatric sickle cell disease: the HESTIA3 study.
Matthew M Heeney, Miguel R Abboud, Jessie Githanga, Baba P D Inusa, Julie Kanter, Adlette Inati

Blood· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of voxelotor in pediatric patients with sickle cell disease aged 4 to 11 years.
Jeremie H Estepp, Ram Kalpatthi, Gerald Woods, Sara Trompeter, Robert I Liem, Adlette Inati

Pediatr Blood Cancer· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eltrombopag in pediatric chronic and refractory ITP: data from a retrospective multicenter study from Lebanon.
Peter Noun, Adlette Inati, Rana Raffoul, Jennifer Abi Younes, Joelle Mardini

Ann Hematol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Wide Variability in the Sensitivity and Specificity of Rotavirus Immunoassay Diagnostic Kits in Practice.
Rouba Shaker, Ebla Abdalrahman, Zainab Ali, Lina Reslan, Houda Harastani, Adlette Inati

J Infect Dev Ctries· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and safety of ticagrelor in infants and toddlers with sickle cell disease aged <24 months.
Baba Psalm Duniva Inusa, Adlette Inati, Philip Maes, Jessie Githanga, Bernhards Ogutu

Pediatr Blood Cancer· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sevuparin for the treatment of acute pain crisis in patients with sickle cell disease: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.
Bart J Biemond, Anil Tombak, Yurdanur Kilinc, Murtadha Al-Khabori, Miguel Abboud, Adlette Inati

Lancet Haematol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Poloxamer 188 vs Placebo on Painful Vaso-Occlusive Episodes in Children and Adults With Sickle Cell Disease: A Randomized Clinical Trial.
James F Casella, Bruce A Barton, Julie Kanter, L Vandy Black, Suvankar Majumdar, Adlette Inati

JAMA· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Features and Outcome of Sickle Cell Disease in a Tertiary Center in Northern Lebanon: A Retrospective Cohort Study in a Local, Hospital-Associated Registry.
Adlette Inati, Chadi Al Alam, Cristel El Ojaimi, Taghrid Hamad, Hemanth Kanakamedala

Hemoglobin· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Full genome characterization of human G3P[6] and G3P[9] rotavirus strains in Lebanon.
Nischay Mishra, Lina Reslan, Mohsen El-Husseini, Hawraa Raoof, Marc Finianos, Adlette Inati

Infect Genet Evol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishment of a formal program for retinoblastoma: Feasibility of clinical coordination across borders and impact on outcome.
Christiane Al-Haddad, Ziad Bashour, Lina Farah, Layal Bayram, Zeina Merabe, Adlette Inati

Pediatr Blood Cancer· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of astrovirus-associated gastroenteritis in hospitalized children under five years of age.
Hassan Zaraket, Hadi Abou-El-Hassan, Khalil Kreidieh, Nadia Soudani, Zainab Ali, Adlette Inati

Infect Genet Evol· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rotavirus Genotypes and Vaccine Effectiveness from a Sentinel, Hospital-Based, Surveillance Study for Three Consecutive Rotavirus Seasons in Lebanon.
Zainab Ali, Houda Harastani, Moza Hammadi, Lina Reslan, Soha Ghanem, Adlette Inati

PLoS One· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transfusion Therapy in Children With Sickle Cell Disease.
Adlette Inati, Anthony G Mansour, Toni Sabbouh, Ghid Amhez, Ahmad Hachem

J Pediatr Hematol Oncol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
One-year results from a prospective randomized trial comparing phlebotomy with deferasirox for the treatment of iron overload in pediatric patients with thalassemia major following curative stem cell transplantation.
Adlette Inati, Mario Kahale, Nada Sbeiti, Maria Domenica Cappellini, Ali T Taher

Pediatr Blood Cancer· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and epidemiological characteristics of norovirus gastroenteritis among hospitalized children in Lebanon.
Nada M Melhem, Hassan Zaraket, Khalil Kreidieh, Zeinab Ali, Moza Hammadi, Adlette Inati

World J Gastroenterol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pediatric Immune Thrombocytopenia in Lebanon: Treatment and Predictors of Outcome.
Adlette Inati, Youssef El Hachem, Sammy Tawk, Sandra Abou Kassm, Hussein A Abbas

Pediatr Blood Cancer· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endocrine and bone complications in β-thalassemia intermedia: current understanding and treatment.
Adlette Inati, MohammadHassan A Noureldine, Anthony Mansour, Hussein A Abbas

Biomed Res Int· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
13-valent pneumococcal conjugate vaccine (PCV13) is immunogenic and safe in children 6-17 years of age with sickle cell disease previously vaccinated with 23-valent pneumococcal polysaccharide vaccine (PPSV23): Results of a phase 3 study.
Mariane De Montalembert, Miguel R Abboud, Anne Fiquet, Adlette Inati, Jeffrey D Lebensburger

Pediatr Blood Cancer· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis